Mass General Brigham is recognized as a national leader in innovation. Our patient-focused approach and systemwide collaboration enable innovators to discover the breakthroughs that are driving medical innovation and improving patient outcomes. We guide innovators through the often-complex process of taking bench research to the bedside to deliver treatments and diagnostics for unmet medical needs, and curative therapies that never were before. We provide an environment that enables and rewards staff-driven innovation.
Achieving successful commercial outcomes that transcend the boundaries between the academic and industrial sectors requires a clear understanding of processes and priorities, the investment environment, and patient needs. This collaborative innovation is where Mass General Brigham Innovation excels.
The path to commercialization involves the aid of our highly talented team, including scientists, physicians, business development and licensing managers, patent attorneys, and others keenly focused on accelerating commercial outcomes and revenues. This includes assessing IP, developing commercialization strategies, creating companies, supporting digital development and tech support, engaging regulatory, reimbursement and domain experts, and investing and accessing translational capital, as well as negotiating deals.
Our devoted team, in addition to its expertise, offers innovators a variety of helpful tools and programs. Among them are educational assets like the MESH Network, funding opportunities for various grants, our popular Innovator’s Commercialization Guide, and simplified forms for submitting an Innovation Disclosure and Material Transfer Agreement, supported by corresponding policies and guidelines.
Ready to act on an invention?
Mass General Brigham is committed to making breakthroughs widespread across the continuum of care. The first step in innovation is creative insight which may occur anywhere and be made by any Mass General Brigham employee.
Disclosing an invention is the first formal action in the commercialization process. The more thorough the initial disclosure, the more rapidly commercialization can proceed.
The path forward from an invention is well defined. It can be complex but rewarding.
